Sun Pharmaceutical Industries Ltd.

The March 2022 quarter revenue stood at Rs. 40068.80 millions, up 9.26% as compared to Rs. 36672.60 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2022 is Rs. -12862.10 millions as compared to Net Profit of Rs. 1848.80 millions of corresponding quarter ended March 2021OP of the company witnessed a marginal growth to 13002.50 millions from 7455.00 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202203	202103	% Var	202203	202103	% Var	202203	202103	% Var
Sales	40068.80	36672.60	9.26	155859.80	141160.50	10.41	155859.80	141160.50	10.41
Other Income	4404.90	382.70	1051.01	11968.80	1920.70	523.15	11968.80	1920.70	523.15
PBIDT	13002.50	7455.00	74.41	38654.40	24490.80	57.83	38654.40	24490.80	57.83
Interest	911.90	1053.10	-13.41	3881.00	2675.20	45.07	3881.00	2675.20	45.07
PBDT	-4459.00	5506.30	-180.98	16568.10	20920.00	-20.80	16568.10	20920.00	-20.80
Depreciation	3541.40	3220.70	9.96	13499.50	12364.30	9.18	13499.50	12364.30	9.18
PBT	-8000.40	2285.60	-450.04	3068.60	8555.70	-64.13	3068.60	8555.70	-64.13
TAX	4861.70	436.80	1013.03	4068.50	131.70	2989.22	4068.50	131.70	2989.22
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	-12862.10	1848.80	-795.70	-999.90	8424.00	-111.87	-999.90	8424.00	-111.87
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	32.45	20.33	59.63	24.80	17.35	42.95	24.80	17.35	42.95